Company news
Ecs Botanics Holdings Ltd news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
ECS launches Vapes and Pastilles
November 12, 2023
$24 Million Supply Agreement with Medicann Health
October 2, 2023
FY23 Full-Year Results - ECS Achieves Positive EBITDA
August 31, 2023
Appendix 4E
August 31, 2023
ECS secures Australian supply agreements worth $11.9m
June 25, 2023
HY Report - Strategy Drives Record Financial Performance
February 27, 2023
Monthly Activities/Appendix 4C Cash Flow Report
January 15, 2023
ECS Secures $9.9m Supply Agreement into Germany
January 3, 2023
Victorian Flood Update
November 6, 2022
Sale Completion of Tasmanian Assets
November 3, 2022
Sale of Tasmanian Assets
October 23, 2022
Appendix 4E Preliminary Final Report
August 31, 2022
Non-dilutive funding and asset sale update
July 21, 2022
ECS Exports First Shipment to New Zealand
July 3, 2022
Focussed Strategy to Maximise Growth
June 13, 2022
Marketing, Operational & Revenue Update
March 7, 2022
HY Report - Increasing Sales Drives Revenue Growth
February 22, 2022
ECS delivers first shipment to the United Kingdom
February 13, 2022
ECS to achieve another consecutive record quarter
January 11, 2022
Prospectus
January 6, 2022
Medicinal cannabis supply agreement with Cannvalate
November 29, 2021
ECS Enters Agreement With Sun Pharma
November 22, 2021
Reinstatement to Official Quotation
November 22, 2021
Suspension from Official Quotation
November 21, 2021
Heavily Supported $6.6m Placement to Drive Expansion
October 28, 2021
ECS to achieve record quarterly revenue
October 7, 2021
ECS secures supply agreement with Canngea
September 7, 2021
ECS secures $1.75m supply agreement into New Zealand
August 29, 2021
Coles to stock ECS Hemp Seed Oil
August 15, 2021
ECS secures $4.5m supply agreement into Europe
July 25, 2021
Strong sales growth following first commercial harvest
June 8, 2021
Launches Innovative range of 30ml Terpene Blends
May 20, 2021
Quarterly Activities Report and Appendix 4C
April 28, 2021
Entitlement Issue Shortfall Notice
April 21, 2021
Maiden commercial medicinal cannabis shipment dispatched
April 16, 2021
Major Expansion planned for Tasmania
April 13, 2021
Supply Agreement with Releaf Dispensaries
March 24, 2021
Entitlement Offer Prospectus
March 17, 2021
ECS successfully completes $4m raising
March 14, 2021
Agreement to Supply Medicinal Cannabis (Amended)
March 4, 2021
Agreement to Supply Medicinal Cannabis
March 3, 2021
Murray Meds signs MOU with Australian based Cannabis Group
March 1, 2021
Murray Meds signs European cannabis oil supply
February 14, 2021
ECS to acquire medicinal cannabis cultivator Murray Meds
January 11, 2021
ECS enters into term sheet with Medipharm Labs
December 23, 2020
TGA Final Decision on Over-the-Counter CBD
December 15, 2020
Proposed issue of Securities - ECS
December 10, 2020
Response to ASX Price Query
December 1, 2020
ECS Medicinal Cannabis Project and Regulatory Update
November 22, 2020
Interim decision reached on scheduling of CBD
September 9, 2020
Decks
The 5 newest of 18 decks. Every deck is listed under its year.
- Tip Conference (October 2026)
Conference · 14 slides · Oct 21, 2026
- Investor Presentation (July 2026)
Investor deck · 18 slides · Jul 28, 2026
- Investor Presentation (May 2026)
Investor deck · 18 slides · May 4, 2026
- H1 FY26 Earnings Presentation
Earnings · 15 slides · Mar 4, 2026
- FY2025 Earnings Presentation
Earnings · 17 slides · Oct 13, 2025